Project Grant R01NS147343
- The National Institute of Neurological Disorders and Stroke, a component of the Department of Health and Human Services National Institutes of Health, awarded $232,605 to the University of Pennsylvania on July 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), a Project Grant assistance type. The recipient will isolate and characterize microglial-derived extracellular vesicles as biomarkers for traumatic brain injury. The...
- The National Institute on Aging awarded the University of Pennsylvania $150,104 on March 1, 2026, under the Aging Research program (CFDA 93.866) to conduct research investigating the role of social relationships in dementia risk among older individuals with traumatic brain injury and among their spouses serving as caregivers. The research examines how interpersonal factors and social engagement modify the association between traumatic brain injury and risk of Alzheimer's disease and related...
- This $3,109,079 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research at the University of California, Riverside to investigate the role of traumatic brain injury (TBI) across the lifespan in the development of Alzheimer's disease and related dementias (ADRD). The project will use a closed head injury (CHI) TBI mouse model to examine how ADRD risk factors, such as the APOE4 gene and amyloid-beta, interact with TBI at different life stages...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research at the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to investigate the mechanisms linking traumatic brain injury (TBI) to subsequent neurodegeneration and dementia. The $1,975,262 award will support a 3-year study...
- This Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to investigate the potential impact of a low-fat, high-fiber diet in limiting traumatic brain injury (TBI)-induced neurodegenerative and inflammatory changes in a mouse model. The $498,713.00 award, with a performance period from July 2024 to June 2027, will support research to...
- The National Institute of Neurological Disorders and Stroke awarded the University of South Florida $568,920 on April 17, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate how traumatic brain injury–induced hypothalamic-pituitary-adrenal (HPA) axis dysregulation affects neuroplasticity and rehabilitation efficacy, with focus on sex differences. The project, titled "Aligning Circuit-Directed Rehabilitation with...
- The National Institute of Neurological Disorders and Stroke awarded Brown University $254,400 on May 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop and evaluate a novel therapeutic targeting brain-derived neurotrophic factor (BDNF) signaling to treat traumatic brain injury. The project will evaluate the efficacy of D-SYN3, a macrocyclic compound targeting the PSD-95 protein to enhance BDNF-TrkB signaling and...
- The National Institute of Neurological Disorders and Stroke awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $1.84 million on September 5, 2026, to investigate phosphodiesterase 2A signaling in traumatic brain injury and Alzheimer's disease under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project examines how phosphodiesterase 2A modulates voltage-dependent anion channel 1...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The University of Pennsylvania a Project Grant totaling $2,817,215 on August 7, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The four-year award, scheduled for completion by July 31, 2029, funds research to elucidate the role of TRIM10 protein in maintaining TDP-43 (TAR DNA-binding protein 43) solubility and...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $423,500 to The University of Kentucky Research Foundation to examine the role of transforming growth factor-activated kinase 1 (TAK1) in tau pathology following repetitive mild traumatic brain injury (TBI). The research aims to determine an optimal dosage and treatment regimen for the novel small molecule therapeutic BNC-1 to reduce TAK1 phosphorylation and tau pathology, neurodegeneration, and...
The National Institute of Neurological Disorders and Stroke awarded The Trustees of the University of Pennsylvania $658,729 on September 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct a pooled cohort study examining associations between traumatic brain injury across the life course and later-life cognitive decline and dementia risk. The research leverages existing data from four NIH-funded ongoing prospective cohort studies with decades of follow-up to identify preventive and mechanistic insights into post-TBI Alzheimer's disease and related dementias. The study tests the central hypothesis that TBI is associated with dementia risk through direct neurodegenerative pathways and through additive or synergistic indirect pathways in combination with other dementia risk factors, with effects potentially differing across the life course. The three specific aims determine the impact of cumulative TBI exposure on cognitive trajectories and dementia risk; quantify how pre- and post-injury vascular risk factor comorbidities influence these associations; and identify potential mechanisms by evaluating associations of TBI with blood-based and brain biomarkers. Performance occurs in Philadelphia, Pennsylvania. The period of performance runs through August 31, 2031. The award is a Project Grant, an assistance type supporting investigator-initiated extramural research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $658.7k | 9/3/26 |